Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection

Early initiation of antiretroviral treatment during primary HIV infection led to negative HIV self-tests and point-of-care tests in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care. Abstract We assessed the impact o...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 2018-05, Vol.217 (11), p.1793-1797
Main Authors: Stefic, Karl, Novelli, Sophie, Mahjoub, Nadia, Seng, Remonie, Molina, Jean-Michel, Cheneau, Christine, Barin, Francis, Chaix, Marie-Laure, Meyer, Laurence, Delaugerre, Constance
Format: Article
Language:English
Subjects:
Adult
Anti-HIV Agents - therapeutic use
Antiretroviral Therapy, Highly Active - methods
Female
HIV Antibodies - immunology
HIV Infections - drug therapy
HIV Infections - immunology
HIV-1 - drug effects
HIV-1 - immunology
Humans
Male
Point-of-Care Testing
Sustained Virologic Response
Viral Load - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c431t-9f374e8babc7156575d1e4b15110acc32a99029b280434285650367b319f2e443
cites cdi_FETCH-LOGICAL-c431t-9f374e8babc7156575d1e4b15110acc32a99029b280434285650367b319f2e443
container_end_page 1797
container_issue 11
container_start_page 1793
container_title The Journal of infectious diseases
container_volume 217
creator Stefic, Karl
Novelli, Sophie
Mahjoub, Nadia
Seng, Remonie
Molina, Jean-Michel
Cheneau, Christine
Barin, Francis
Chaix, Marie-Laure
Meyer, Laurence
Delaugerre, Constance
description Early initiation of antiretroviral treatment during primary HIV infection led to negative HIV self-tests and point-of-care tests in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care. Abstract We assessed the impact of early antiretroviral treatment (ART) on human immunodeficiency virus (HIV) antibody detection by rapid tests in 44 individuals after several years of successful ART. HIV self-tests and point-of-care tests were negative in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care.
doi_str_mv 10.1093/infdis/jiy120
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2011613131</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/infdis/jiy120</oup_id><sourcerecordid>2011613131</sourcerecordid><originalsourceid>FETCH-LOGICAL-c431t-9f374e8babc7156575d1e4b15110acc32a99029b280434285650367b319f2e443</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS1URKfTLtkiL9mE-trJZLwcFYaOVBUE024jx7kBV4kd_NNqXocnJWlKu6zuwro6n47tcwh5D-wTMCnOjW0bE87vzAE4e0MWUIgyW61AHJEFY5xnsJbymJyEcMcYy8WqfEeOuSyYlDxfkL_XznpUOpp7pJepV5bu-j5Z12BrtEGrD_TW-BTo_jAgBfpDDaahewwx0E0b0dOfKURlLDYTqLpxHwaPIRhn6dZ1nXsw9hfd2Gg8Ru_uH6H9b_RqONCdNdGoOLGfk5_A7970yk9Ki3oSTsnbVnUBz57OJbnZftlfXGZX377uLjZXmc4FxEy2osxxXatal1CsirJoAPMaCgCmtBZcScm4rPl6TCHn6xFhYxq1ANlyzHOxJB9n38G7P2n8YNWboLHrlEWXQsUZwJjrNEuSzaj2LgSPbTXMr66AVVMt1VxLNdcy8h-erFPdY_NM_-_h5W6Xhle8_gF5GZtF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2011613131</pqid></control><display><type>article</type><title>Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection</title><source>Oxford Journals Online</source><creator>Stefic, Karl ; Novelli, Sophie ; Mahjoub, Nadia ; Seng, Remonie ; Molina, Jean-Michel ; Cheneau, Christine ; Barin, Francis ; Chaix, Marie-Laure ; Meyer, Laurence ; Delaugerre, Constance</creator><creatorcontrib>Stefic, Karl ; Novelli, Sophie ; Mahjoub, Nadia ; Seng, Remonie ; Molina, Jean-Michel ; Cheneau, Christine ; Barin, Francis ; Chaix, Marie-Laure ; Meyer, Laurence ; Delaugerre, Constance ; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group ; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group</creatorcontrib><description>Early initiation of antiretroviral treatment during primary HIV infection led to negative HIV self-tests and point-of-care tests in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care. Abstract We assessed the impact of early antiretroviral treatment (ART) on human immunodeficiency virus (HIV) antibody detection by rapid tests in 44 individuals after several years of successful ART. HIV self-tests and point-of-care tests were negative in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/jiy120</identifier><identifier>PMID: 29509924</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adult ; Anti-HIV Agents - therapeutic use ; Antiretroviral Therapy, Highly Active - methods ; Female ; HIV Antibodies - immunology ; HIV Infections - drug therapy ; HIV Infections - immunology ; HIV-1 - drug effects ; HIV-1 - immunology ; Humans ; Male ; Point-of-Care Testing ; Sustained Virologic Response ; Viral Load - methods</subject><ispartof>The Journal of infectious diseases, 2018-05, Vol.217 (11), p.1793-1797</ispartof><rights>The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c431t-9f374e8babc7156575d1e4b15110acc32a99029b280434285650367b319f2e443</citedby><cites>FETCH-LOGICAL-c431t-9f374e8babc7156575d1e4b15110acc32a99029b280434285650367b319f2e443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29509924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stefic, Karl</creatorcontrib><creatorcontrib>Novelli, Sophie</creatorcontrib><creatorcontrib>Mahjoub, Nadia</creatorcontrib><creatorcontrib>Seng, Remonie</creatorcontrib><creatorcontrib>Molina, Jean-Michel</creatorcontrib><creatorcontrib>Cheneau, Christine</creatorcontrib><creatorcontrib>Barin, Francis</creatorcontrib><creatorcontrib>Chaix, Marie-Laure</creatorcontrib><creatorcontrib>Meyer, Laurence</creatorcontrib><creatorcontrib>Delaugerre, Constance</creatorcontrib><creatorcontrib>French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group</creatorcontrib><creatorcontrib>French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group</creatorcontrib><title>Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Early initiation of antiretroviral treatment during primary HIV infection led to negative HIV self-tests and point-of-care tests in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care. Abstract We assessed the impact of early antiretroviral treatment (ART) on human immunodeficiency virus (HIV) antibody detection by rapid tests in 44 individuals after several years of successful ART. HIV self-tests and point-of-care tests were negative in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care.</description><subject>Adult</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral Therapy, Highly Active - methods</subject><subject>Female</subject><subject>HIV Antibodies - immunology</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - immunology</subject><subject>HIV-1 - drug effects</subject><subject>HIV-1 - immunology</subject><subject>Humans</subject><subject>Male</subject><subject>Point-of-Care Testing</subject><subject>Sustained Virologic Response</subject><subject>Viral Load - methods</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNqFkc1u1DAUhS1URKfTLtkiL9mE-trJZLwcFYaOVBUE024jx7kBV4kd_NNqXocnJWlKu6zuwro6n47tcwh5D-wTMCnOjW0bE87vzAE4e0MWUIgyW61AHJEFY5xnsJbymJyEcMcYy8WqfEeOuSyYlDxfkL_XznpUOpp7pJepV5bu-j5Z12BrtEGrD_TW-BTo_jAgBfpDDaahewwx0E0b0dOfKURlLDYTqLpxHwaPIRhn6dZ1nXsw9hfd2Gg8Ru_uH6H9b_RqONCdNdGoOLGfk5_A7970yk9Ki3oSTsnbVnUBz57OJbnZftlfXGZX377uLjZXmc4FxEy2osxxXatal1CsirJoAPMaCgCmtBZcScm4rPl6TCHn6xFhYxq1ANlyzHOxJB9n38G7P2n8YNWboLHrlEWXQsUZwJjrNEuSzaj2LgSPbTXMr66AVVMt1VxLNdcy8h-erFPdY_NM_-_h5W6Xhle8_gF5GZtF</recordid><startdate>20180505</startdate><enddate>20180505</enddate><creator>Stefic, Karl</creator><creator>Novelli, Sophie</creator><creator>Mahjoub, Nadia</creator><creator>Seng, Remonie</creator><creator>Molina, Jean-Michel</creator><creator>Cheneau, Christine</creator><creator>Barin, Francis</creator><creator>Chaix, Marie-Laure</creator><creator>Meyer, Laurence</creator><creator>Delaugerre, Constance</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20180505</creationdate><title>Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection</title><author>Stefic, Karl ; Novelli, Sophie ; Mahjoub, Nadia ; Seng, Remonie ; Molina, Jean-Michel ; Cheneau, Christine ; Barin, Francis ; Chaix, Marie-Laure ; Meyer, Laurence ; Delaugerre, Constance</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c431t-9f374e8babc7156575d1e4b15110acc32a99029b280434285650367b319f2e443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral Therapy, Highly Active - methods</topic><topic>Female</topic><topic>HIV Antibodies - immunology</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - immunology</topic><topic>HIV-1 - drug effects</topic><topic>HIV-1 - immunology</topic><topic>Humans</topic><topic>Male</topic><topic>Point-of-Care Testing</topic><topic>Sustained Virologic Response</topic><topic>Viral Load - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stefic, Karl</creatorcontrib><creatorcontrib>Novelli, Sophie</creatorcontrib><creatorcontrib>Mahjoub, Nadia</creatorcontrib><creatorcontrib>Seng, Remonie</creatorcontrib><creatorcontrib>Molina, Jean-Michel</creatorcontrib><creatorcontrib>Cheneau, Christine</creatorcontrib><creatorcontrib>Barin, Francis</creatorcontrib><creatorcontrib>Chaix, Marie-Laure</creatorcontrib><creatorcontrib>Meyer, Laurence</creatorcontrib><creatorcontrib>Delaugerre, Constance</creatorcontrib><creatorcontrib>French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group</creatorcontrib><creatorcontrib>French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stefic, Karl</au><au>Novelli, Sophie</au><au>Mahjoub, Nadia</au><au>Seng, Remonie</au><au>Molina, Jean-Michel</au><au>Cheneau, Christine</au><au>Barin, Francis</au><au>Chaix, Marie-Laure</au><au>Meyer, Laurence</au><au>Delaugerre, Constance</au><aucorp>French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group</aucorp><aucorp>French National Agency for Research on AIDS and Viral Hepatitis (ANRS) PRIMO Study Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>2018-05-05</date><risdate>2018</risdate><volume>217</volume><issue>11</issue><spage>1793</spage><epage>1797</epage><pages>1793-1797</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><abstract>Early initiation of antiretroviral treatment during primary HIV infection led to negative HIV self-tests and point-of-care tests in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care. Abstract We assessed the impact of early antiretroviral treatment (ART) on human immunodeficiency virus (HIV) antibody detection by rapid tests in 44 individuals after several years of successful ART. HIV self-tests and point-of-care tests were negative in 30% and 7%–9% of cases, respectively. These data reinforce the message that patients should never be retested after entering HIV care.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>29509924</pmid><doi>10.1093/infdis/jiy120</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 2018-05, Vol.217 (11), p.1793-1797
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_2011613131
source Oxford Journals Online
subjects Adult
Anti-HIV Agents - therapeutic use
Antiretroviral Therapy, Highly Active - methods
Female
HIV Antibodies - immunology
HIV Infections - drug therapy
HIV Infections - immunology
HIV-1 - drug effects
HIV-1 - immunology
Humans
Male
Point-of-Care Testing
Sustained Virologic Response
Viral Load - methods
title Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T02%3A49%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nonreactive%20Human%20Immunodeficiency%20Virus%20Type%201%20Rapid%20Tests%20After%20Sustained%20Viral%20Suppression%20Following%20Antiretroviral%20Therapy%20Initiation%20During%20Primary%20Infection&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Stefic,%20Karl&rft.aucorp=French%20National%20Agency%20for%20Research%20on%20AIDS%20and%20Viral%20Hepatitis%20(ANRS)%20PRIMO%20Study%20Group&rft.date=2018-05-05&rft.volume=217&rft.issue=11&rft.spage=1793&rft.epage=1797&rft.pages=1793-1797&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/jiy120&rft_dat=%3Cproquest_cross%3E2011613131%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c431t-9f374e8babc7156575d1e4b15110acc32a99029b280434285650367b319f2e443%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2011613131&rft_id=info:pmid/29509924&rft_oup_id=10.1093/infdis/jiy120&rfr_iscdi=true